Minoxidil (Mx) as a prophylaxis of doxorubicin - induced alopecia

54Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Minoxidil (Mx) is known to induce hair growth in men with male-pattern baldness. Based on this potential, the effectiveness of Mx 2% topical solution was evaluated in cancer patients (pts) to prevent doxorubicin-induced alopecia. Patients and methods: 48 female pts with different types of solid tumors treated with doxorubicin-based chemotherapy in a dose range of 50-60 mg/m2/cycle were randomly assigned to receive Mx 2% topical solution or placebo. Results: 88% and 92% of pts in both arms showed severe alopecia (p - ns). No adverse effects were observed. Conclusions: In this study Mx 2% topical solution was non-toxic but was not effective in the prevention of chemotherapy-induced alopecia. © 1994 Kluwer Academic Publishers.

Cite

CITATION STYLE

APA

Rodriguez, R., Machiavelli, M., Leone, B., Romero, A., Cuevas, M. A., Langhi, M., … Lacava, J. (1994). Minoxidil (Mx) as a prophylaxis of doxorubicin - induced alopecia. Annals of Oncology, 5(8), 769–770. https://doi.org/10.1093/oxfordjournals.annonc.a058986

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free